Cedeño, Kendra .

HRN: 29-50-39  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/20/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/20/2026
08/26/2026
IV
500mg
Q6
Injury
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft TissueReproductive Tract    Compliance to guidelines: